{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:38Z","timestamp":1792098578626,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.autrev.2017.05.008","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T10:32:53Z","timestamp":1493893973000},"page":"722-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"title":["Interstital lung disease in ANCA vasculitis"],"prefix":"10.1016","volume":"16","author":[{"given":"Marco A.","family":"Alba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Flores-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley G.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Nachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Charles Jennette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.05.008_bb0005","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.008_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0031-1279822","article-title":"Pathogenesis of lung vasculitis","volume":"32","author":"Nachman","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0025","first-page":"427","article-title":"Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee","volume":"83","author":"Anderson","year":"1992","journal-title":"Q J Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.autrev.2014.08.017","article-title":"Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment","volume":"13","author":"Comarmond","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.008_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/rheumatology\/kev286","article-title":"Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort","volume":"55","author":"Schirmer","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.008_bb0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.008_bb0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.autrev.2010.07.009","article-title":"Microscopic polyangiitis: clinical presentation","volume":"9","author":"Villiger","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.008_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2172-15-20","article-title":"Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow-up in ANCA-associated vasculitis","volume":"15","author":"Hassan","year":"2014","journal-title":"BMC Immunol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3899\/jrheum.130602","article-title":"Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan","volume":"41","author":"Furuta","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0060","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.008_bb0065","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.rmed.2008.04.023","article-title":"ANCA-associated lung fibrosis: analysis of 17 patients","volume":"102","author":"Foulon","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0070","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0025-6196(12)62575-0","article-title":"Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients","volume":"65","author":"Nada","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2017.05.008_bb0075","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2008.096131","article-title":"Vasculitis study, pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature","volume":"68","author":"Hervier","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.008_bb0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000183754","article-title":"A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients","volume":"77","author":"Nozu","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.autrev.2017.05.008_bb0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1183\/09031936.00110109","article-title":"Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis","volume":"36","author":"Tzelepis","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2017.05.008_bb0090","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/rheumatology\/ker236","article-title":"Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study","volume":"50","author":"Arulkumaran","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.008_bb0095","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s10067-015-2967-1","article-title":"Reduced survival in microscopic polyangiitis patients with pulmonary fibrosis in a respiratory referral centre","volume":"34","author":"Flores-Suarez","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0100","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10067-014-2676-1","article-title":"Microscopic polyangiitis associated with pulmonary fibrosis","volume":"34","author":"Fernandez Casares","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1378\/chest.123.1.297","article-title":"Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis","volume":"123","author":"Eschun","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2017.05.008_bb0110","first-page":"384","article-title":"Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis","volume":"53","author":"Hiromura","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0115","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/s10165-009-0182-0","article-title":"Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experience","volume":"19","author":"Nakabayashi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10157-010-0390-0","article-title":"Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases","volume":"15","author":"Nakabayashi","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0125","first-page":"921","article-title":"Prevalence of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPO-ANCA) in patients with interstitial pneumonia","volume":"45","author":"Shiraki","year":"2007","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.autrev.2017.05.008_bb0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","article-title":"Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides","volume":"9","author":"Homma","year":"2004","journal-title":"Respirology"},{"key":"10.1016\/j.autrev.2017.05.008_bb0135","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.rmed.2012.08.024","article-title":"Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients","volume":"106","author":"Tanaka","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/03009749950155643","article-title":"Fibrosing alveolitis predating microscopic polyangiitis","volume":"28","author":"Becker-Merok","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0145","first-page":"351","article-title":"Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?","volume":"3","author":"Bhanji","year":"2010","journal-title":"NDT Plus"},{"key":"10.1016\/j.autrev.2017.05.008_bb0150","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/art.22633","article-title":"Microscopic polyangiitis presenting as a \u201cpulmonary-muscle\u201d syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis?","volume":"56","author":"Birnbaum","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.008_bb0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00000441-200103000-00009","article-title":"Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis: is anti-neutrophilic cytoplasmic antibody testing indicated?","volume":"321","author":"Mansi","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.autrev.2017.05.008_bb0160","first-page":"329","article-title":"Pulmonary fibrosis associated with anti-neutrophil cytoplasmic antibody positive vasculitis","volume":"72","author":"Fernandez Casares","year":"2012","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.autrev.2017.05.008_bb0165","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0755-4982(06)74799-6","article-title":"Churg-Strauss syndrome and pulmonary fibrosis: an unusual association","volume":"35","author":"Streho","year":"2006","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2332\/allergolint.10-CR-0216","article-title":"A case of microscopic polyangiitis following mycoplasma infection in a patient with MPO-ANCA positive pulmonary fibrosis","volume":"60","author":"Takato","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.autrev.2017.05.008_bb0175","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1183\/09031936.00216311","article-title":"Combined pulmonary fibrosis and emphysema associated with microscopic polyangiitis","volume":"40","author":"Tzouvelekis","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2017.05.008_bb0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12890-015-0129-5","article-title":"Idiopathic lung fibrosis and anti myeloperoxidase glomerulonephritis: the tree that hides the forest","volume":"15","author":"Pineton de Chambrun","year":"2015","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0185","first-page":"145","article-title":"Pulmonary fibrosis in patients with positive neutrophil cytoplasmic antibodies vasculitis","volume":"34","author":"Tomas Chaume","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0190","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-005-0142-9","article-title":"A case of myeloperoxidase-antineutrophil cytoplasmic antibody positive-polyarteritis nodosa complicated by interstitial pneumonia and rapidly progressive renal failure","volume":"26","author":"Sugimoto","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0195","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00199387","article-title":"Fibrosing vasculitis in Wegener's granulomatosis: ultrastructural and immunohistochemical analysis of the vascular lesions","volume":"427","author":"Gindre","year":"1995","journal-title":"Virchows Arch"},{"key":"10.1016\/j.autrev.2017.05.008_bb0200","first-page":"337","article-title":"Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution","volume":"55","author":"Souid","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.01.2011.3692","article-title":"Pyrexia of unknown origin and pulmonary fibrosis as a presentation of MPO-ANCA associated vasculitis","volume":"2011","author":"Shields","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2017.05.008_bb0210","first-page":"141","article-title":"Pulmonary fibrosis presenting as an early manifestation of microscopic polyangiitis","volume":"77","author":"Eleftheriou","year":"2012","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.autrev.2017.05.008_bb0215","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.201504-0818OC","article-title":"Idiopathic pulmonary fibrosis in United States automated claims. Incidence, prevalence, and algorithm validation","volume":"192","author":"Esposito","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0220","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.autrev.2014.01.037","article-title":"Diagnosis and classification of idiopathic pulmonary fibrosis","volume":"13","author":"Kekevian","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.008_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajcp\/104.1.7","article-title":"The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase","volume":"104","author":"Gaudin","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0230","doi-asserted-by":"crossref","first-page":"e94775","DOI":"10.1371\/journal.pone.0094775","article-title":"Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis","volume":"9","author":"Kono","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.008_bb0235","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s10157-012-0733-0","article-title":"Limited pulmonary MPA, a new MPA entity? A rheumatologist's perspective","volume":"17","author":"Flores-Suarez","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0240","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2466-14-8","article-title":"A retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0245","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.clinthera.2014.09.025","article-title":"Computed tomography image analysis before and after treatment of anti-neutrophil cytoplasmic antibody-associated pulmonary interstitial fibrosis in 8 patients","volume":"36","author":"Yu","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.autrev.2017.05.008_bb0250","doi-asserted-by":"crossref","first-page":"e000058","DOI":"10.1136\/bmjresp-2014-000058","article-title":"Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis","volume":"2","author":"Kagiyama","year":"2015","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.autrev.2017.05.008_bb0255","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MD.0000000000000217","article-title":"Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature","volume":"93","author":"Comarmond","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.05.008_bb0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MD.0b013e31817c744b","article-title":"Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients","volume":"87","author":"Chen","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.05.008_bb0265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00408-004-2540-1","article-title":"Development of microscopic polyangiitis in patients with chronic airway disease","volume":"183","author":"Takahashi","year":"2005","journal-title":"Lung"},{"key":"10.1016\/j.autrev.2017.05.008_bb0270","first-page":"51","article-title":"Interstitial lung disease with ANCA-associated Vasculitis","volume":"9","author":"Katsumata","year":"2015","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2017.05.008_bb0275","doi-asserted-by":"crossref","first-page":"i83","DOI":"10.1093\/ndt\/gfu385","article-title":"Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan","volume":"30","author":"Hirayama","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2017.05.008_bb0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00408-016-9851-x","article-title":"Clinical implication of proteinase-3-antineutrophil cytoplasmic antibody in patients with idiopathic interstitial pneumonias","volume":"194","author":"Hozumi","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.autrev.2017.05.008_bb0285","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3346\/jkms.2013.28.5.731","article-title":"Clinical significance of serum autoantibodies in idiopathic interstitial pneumonia","volume":"28","author":"Kang","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2017.05.008_bb0290","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.rmed.2013.01.006","article-title":"Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis","volume":"107","author":"Ando","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0295","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/resp.12763","article-title":"Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis","volume":"21","author":"Hosoda","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.autrev.2017.05.008_bb0300","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2332\/allergolint.14-RAI-0778","article-title":"Current concept and epidemiology of systemic vasculitides","volume":"63","author":"Katsuyama","year":"2014","journal-title":"Allergol Int"},{"key":"10.1016\/j.autrev.2017.05.008_bb0305","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1164\/ajrccm.177.12.1397a","article-title":"Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients","volume":"177","author":"Azuma","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0310","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1093\/ndt\/gfn354","article-title":"Renal vasculitis in Japan and the UK\u2014are there differences in epidemiology and clinical phenotype?","volume":"23","author":"Watts","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2017.05.008_bb0315","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0031-1279828","article-title":"ANCA: associated lung fibrosis","volume":"32","author":"Yamada","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0320","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.39475","article-title":"Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis: a multicenter, longitudinal, retrospective study of one hundred fifty consecutive hospital-based Japanese patients","volume":"68","author":"Yamagata","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.008_bb0325","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/01.rct.0000135280.79012.c7","article-title":"Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease. CT findings in 51 patients","volume":"28","author":"Ando","year":"2004","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.autrev.2017.05.008_bb0330","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0335","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"S. American Thoracic","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0340","first-page":"128","article-title":"Microscopic polyangiitis preceded by combined pulmonary fibrosis and emphysema","volume":"15","author":"Gocho","year":"2015","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.autrev.2017.05.008_bb0345","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00000478-199104000-00001","article-title":"Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients","volume":"15","author":"Travis","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0350","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1399-3003.1999.14a20.x","article-title":"Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity","volume":"14","author":"Schnabel","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2017.05.008_bb0355","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1183\/09031936.00148409","article-title":"The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis","volume":"37","author":"Guilpain","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2017.05.008_bb0360","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/ajrccm.160.3.9807139","article-title":"Antimyeloperoxidase-associated lung disease. An experimental model","volume":"160","author":"Foucher","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0365","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1465-9921-6-83","article-title":"Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models","volume":"6","author":"Lucattelli","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.autrev.2017.05.008_bb0370","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1164\/rccm.201311-1932OC","article-title":"Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease","volume":"189","author":"Gehrig","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0375","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1165\/ajrcmb\/1.4.289","article-title":"Human lung fibroblast-derived granulocyte-macrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro","volume":"1","author":"Vancheri","year":"1989","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0380","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1378\/chest.92.1.51","article-title":"Prognostic role of eosinophils in pulmonary fibrosis","volume":"92","author":"Peterson","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2017.05.008_bb0385","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.4359","article-title":"Neutrophil extracellular traps promote differentiation and function of fibroblasts","volume":"233","author":"Chrysanthopoulou","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0390","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/nep.12736","volume":"21","author":"Yoshida","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.autrev.2017.05.008_bb0395","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1165\/rcmb.4791","article-title":"Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice","volume":"27","author":"Churg","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0400","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.autrev.2014.08.028","article-title":"Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis","volume":"13","author":"Yan","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.008_bb0405","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0046-8177(88)80088-1","article-title":"The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis: a study based on 35 open lung biopsies","volume":"19","author":"Mark","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0410","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0046-8177(86)80465-8","article-title":"Pulmonary lesions in Wegener's granulomatosis: a clinicopathologic study of 22 autopsy cases","volume":"17","author":"Yoshikawa","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0415","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.autrev.2012.08.007","article-title":"Treatment of ANCA-associated vasculitides (AAV)","volume":"12","author":"Holle","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.008_bb0420","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.008_bb0425","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3899\/jrheum.150376","article-title":"CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides","volume":"43","author":"McGeoch","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0430","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","article-title":"BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.008_bb0435","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0440","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kei211","article-title":"Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease","volume":"45","author":"Liossis","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.008_bb0445","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0450","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.semarthrit.2014.09.002","article-title":"Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis","volume":"44","author":"Bosello","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.008_bb0455","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/resp.12214","article-title":"Rituximab in severe, treatment-refractory interstitial lung disease","volume":"19","author":"Keir","year":"2014","journal-title":"Respirology"},{"issue":"Suppl. 100","key":"10.1016\/j.autrev.2017.05.008_bb0460","first-page":"181","article-title":"Effects of rituximab in connective tissue disorders related interstitial lung disease","volume":"34","author":"Lepri","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.008_bb0465","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.05.008_bb0470","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S2213-2600(16)30326-5","article-title":"Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis","volume":"5","author":"Nathan","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0475","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.05.008_bb0480","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T04:50:29Z","timestamp":1535863829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":96,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1568997217301283"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.008","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interstital lung disease in ANCA vasculitis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}